Graciela Diap
Publications by Year
Research Areas
Malaria Research and Control, Pharmaceutical Economics and Policy, Global Maternal and Child Health, Pharmaceutical Quality and Counterfeiting, Hepatitis C virus research
Most-Cited Works
- → Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission(2019)533 cited
- → Effect of the Affordable Medicines Facility—malaria (AMFm) on the availability, price, and market share of quality-assured artemisinin-based combination therapies in seven countries: a before-and-after analysis of outlet survey data(2012)173 cited
- → New, Improved Treatments for Chagas Disease: From the R&D Pipeline to the Patients(2009)158 cited
- → Drug policy for visceral leishmaniasis: a cost‐effectiveness analysis(2007)55 cited
- → The story of artesunate–mefloquine (ASMQ), innovative partnerships in drug development: case study(2013)48 cited
- → Communicating the AMFm message: exploring the effect of communication and training interventions on private for-profit provider awareness and knowledge related to a multi-country anti-malarial subsidy intervention(2014)48 cited
- → Availability and price of malaria rapid diagnostic tests in the public and private health sectors in 2011: results from 10 nationally representative cross‐sectional retail surveys(2015)38 cited
- → Anti-malarial market and policy surveys in sub-Saharan Africa(2010)23 cited
- → Improving Access To Malaria Medicine Through Private-Sector Subsidies In Seven African Countries(2014)22 cited
- → Access to artesunate-amodiaquine, quinine and other anti-malarials: policy and markets in Burundi(2011)14 cited